Panion presents at Animal Health Investment Europe, London, on 27 February 2019

Panion Animal Health AB develops an innovative treatment for epilepsy in dogs and has just started the clinical phase.

Panion has been selected to present its business plan at the 2019 Animal Health Investment Forum as part of the Innovation Showcase of the year, in the programme on translational technology from human-to-veterinary pharma.

Panion’s chairman of the board, Lars Thunberg, will inform the audience about the promising business idea in veterinary medicines and the progress over the last two years. The focus will be on the commercial elements of Panion’s business plan and sets out the possible road to commercialisation.

The Animal Health Investment Europe is a premier investment forum showcasing the most exciting investment opportunities in animal health and nutrition and connecting those businesses with financial investors and strategic corporate partners.

The presentation slides can be seen here: https://bit.ly/2Iyn4p4

Anja E. H. Holm, CEO
+ 45-22 94 66 00
anja.holm@panion-animalhealth.com

Bolaget ska utveckla och kommersialisera genterapi för behandling av epilepsiliknande tillstånd hos hundar och andra djur, samt utveckla och kommersialisera andra veterinärmedicinska produkter och nya behandlingsformer som kan ge sjuka djur bättre livskvalitet.
Panion will develop and commercialize a gene therapy treatment for dogs with drug refractory epilepsy, and other new animal health products and treatments that improve the quality of life for animals suffering from chronic diseases.